Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes.

Ruderman NB, Cacicedo JM, Itani S, Yagihashi N, Saha AK, Ye JM, Chen K, Zou M, Carling D, Boden G, Cohen RA, Keaney J, Kraegen EW, Ido Y.

Biochem Soc Trans. 2003 Feb;31(Pt 1):202-6. Review.

PMID:
12546685
2.

AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.

Hopkins TA, Dyck JR, Lopaschuk GD.

Biochem Soc Trans. 2003 Feb;31(Pt 1):207-12. Review.

PMID:
12546686
3.

LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.

Thomson DM, Brown JD, Fillmore N, Condon BM, Kim HJ, Barrow JR, Winder WW.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1572-9. Epub 2007 Oct 9.

5.

AMP-activated protein kinase in metabolic control and insulin signaling.

Towler MC, Hardie DG.

Circ Res. 2007 Feb 16;100(3):328-41. Review.

6.

AMP-activated protein kinase regulation and action in skeletal muscle during exercise.

Musi N, Yu H, Goodyear LJ.

Biochem Soc Trans. 2003 Feb;31(Pt 1):191-5. Review.

PMID:
12546683
9.

Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.

Kraegen EW, Saha AK, Preston E, Wilks D, Hoy AJ, Cooney GJ, Ruderman NB.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E471-9. Epub 2005 Oct 18.

10.

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species.

Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG 4th, Schlattner U, Neumann D, Brownlee M, Freeman MB, Goldman MH.

J Biol Chem. 2004 Oct 15;279(42):43940-51. Epub 2004 Jul 19.

12.
13.

Insulin resistance and improvements in signal transduction.

Musi N, Goodyear LJ.

Endocrine. 2006 Feb;29(1):73-80. Review.

PMID:
16622294
14.

Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle.

Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E182-9. Epub 2006 Feb 14.

15.

Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ.

Diabetes. 2002 Jul;51(7):2074-81.

17.

AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

Cacicedo JM, Yagihashi N, Keaney JF Jr, Ruderman NB, Ido Y.

Biochem Biophys Res Commun. 2004 Nov 26;324(4):1204-9.

PMID:
15504342
18.

AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.

Raney MA, Yee AJ, Todd MK, Turcotte LP.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E592-8. Epub 2004 Nov 16.

19.

The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity.

Steinberg GR, Jørgensen SB.

Mini Rev Med Chem. 2007 May;7(5):519-26. Review.

PMID:
17504187
20.

Malonyl-CoA, fuel sensing, and insulin resistance.

Ruderman NB, Saha AK, Vavvas D, Witters LA.

Am J Physiol. 1999 Jan;276(1 Pt 1):E1-E18. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk